Retrospective Study
Copyright ©The Author(s) 2024.
World J Cardiol. Sep 26, 2024; 16(9): 512-521
Published online Sep 26, 2024. doi: 10.4330/wjc.v16.i9.512
Figure 1
Figure 1 Flowchart showing the inclusion data for the analysis.
Figure 2
Figure 2 Frequency of major adverse cardiac and cerebrovascular events in young (18-44 years) cannabis users (1152700) vs non-users (26323036). Pearson’s χ² test and Kruskal Wallis test are used to analyze the categorical and continuous variables. CUD: Cannabis use disorder; MACCE: Major adverse cardiac and cerebrovascular events.
Figure 3
Figure 3 Trends in hospitalizations for major cardiovascular and cerebrovascular events among cannabis users vs. non-users of age 18-44 years, excluding cases with concomitant substance abuse (Alcohol, tobacco, and cocaine) from 2016-2019. A: Trends in hospitalizations for major adverse cardiac and cerebrovascular events; B: Trends in hospitalizations for all-cause mortality; C: Trends in hospitalizations for acute myocardial infarction; D: Trends in hospitalizations for cardiac arrest; E: Trends in hospitalizations for stroke. CUD: Cannabis use disorder.